Jan N. Basile, MD Associate Professor of Medicine, Ralph H. Johnson VA Medical Center, Medical University of South Carolina, Charleston, SC
Address: Jan N. Basile, MD, Ralph H. Johnson VA Medical Center, 109 Bee St, Charleston, SC 29403
Dr. Basile has received grant support from Novartis Pharmaceuticals, has served as a consultant for Forest Pharmaceuticals, and is on the speakers’ bureau for AstraZeneca, Merck, Novartis Pharmaceuticals, Pfizer, Solvay, and Wyeth-Ayerst.
This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.
ABSTRACTFinding the optimal combination of drugs in the correct dosages, which requires careful monitoring over time, is key to slowing the disease process and prolonging life. For most patients, treating heart failure involves correcting underlying left ventricular dysfunction, thereby slowing the remodeling process.
